CHARGE THERAPEUTICS

Serial Number 99148525
681

Registration Progress

Application Filed
Apr 22, 2025
Under Examination
Approved for Publication
Published for Opposition
Nov 25, 2025
Registered

Attorney Assistance

Non-Final Action Mailed
Due: Dec 22, 2025 47 days

Trademark Image

CHARGE THERAPEUTICS

Basic Information

Serial Number
99148525
Filing Date
April 22, 2025
Published for Opposition
November 25, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
681
Status Date
Nov 3, 2025
Application
Pending
Classes
005 042

Rights Holder

STEALTH BIOTHERAPEUTICS INC.

03
Address
123 Highland Ave, Suite 201
Needham, MA 02494

Ownership History

STEALTH BIOTHERAPEUTICS INC.

Original Applicant
03
Needham, MA

Legal Representation

Attorney
Tricia L. Schulz

USPTO Deadlines

Next Deadline
47 days remaining
Non-Final Action Mailed
Due Date
December 22, 2025
Extension Available
Until March 22, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

12 events
Date Code Type Description Documents
Oct 23, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 23, 2025 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Oct 23, 2025 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Oct 23, 2025 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Oct 23, 2025 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Sep 22, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 22, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Sep 22, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 15, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 28, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 22, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Apr 22, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Biopharmaceutical preparations for the treatment of mitochondrial, cardiovascular, renal, ophthalmic, neurologic and metabolic diseases and disorders; Pharmaceutical preparations for the prevention of mitochondrial, cardiovascular, renal, ophthalmic, neurologic and metabolic diseases and disorders; Biological preparations for the treatment of cellular abnormalities
Class 042
Scientific research and development; biopharmaceutical research, development and testing; Medical and scientific research in the field of mitochondrial, cardiovascular, renal, ophthalmic, neurologic, myopathic and metabolic systems

Classification

International Classes
005 042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"